Eintrag weiter verarbeiten
Use of rifampin in nonstaphylococcal, nonmycobacterial disease
Gespeichert in:
| Zeitschriftentitel: | Antimicrobial Agents and Chemotherapy |
|---|---|
| Personen und Körperschaften: | , , |
| In: | Antimicrobial Agents and Chemotherapy, 37, 1993, 1, S. 1-7 |
| Format: | E-Article |
| Sprache: | Englisch |
| veröffentlicht: |
American Society for Microbiology
|
| Schlagwörter: |
| author_facet |
Morris, A B Brown, R B Sands, M Morris, A B Brown, R B Sands, M |
|---|---|
| author |
Morris, A B Brown, R B Sands, M |
| spellingShingle |
Morris, A B Brown, R B Sands, M Antimicrobial Agents and Chemotherapy Use of rifampin in nonstaphylococcal, nonmycobacterial disease Infectious Diseases Pharmacology (medical) Pharmacology |
| author_sort |
morris, a b |
| spelling |
Morris, A B Brown, R B Sands, M 0066-4804 1098-6596 American Society for Microbiology Infectious Diseases Pharmacology (medical) Pharmacology http://dx.doi.org/10.1128/aac.37.1.1 <jats:p>Rifampin has very broad antimicrobial properties with in vitro activities against many bacteria, mycobacteria, higher bacteria, chlamydia, fungi, parasites, and viruses (Table 1). The clinical use of rifampin is more limited, in part because of the lack of in vivo human clinical studies demonstrating its efficacy. Investigators have valid concerns regarding the emergence of resistance of mycobacteria if widespread use of rifampin becomes common, although this has not been well documented. Because rifampin obtains therapeutic levels intracellularly and is distributed widely throughout the body, the antibiotic potentially could be used on a broader scale, but more studies will be needed to demonstrate its clinical utility.</jats:p> Use of rifampin in nonstaphylococcal, nonmycobacterial disease Antimicrobial Agents and Chemotherapy |
| doi_str_mv |
10.1128/aac.37.1.1 |
| facet_avail |
Online Free |
| finc_class_facet |
Medizin Chemie und Pharmazie |
| format |
ElectronicArticle |
| fullrecord |
blob:ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTEyOC9hYWMuMzcuMS4x |
| id |
ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTEyOC9hYWMuMzcuMS4x |
| institution |
DE-D275 DE-Bn3 DE-Brt1 DE-Zwi2 DE-D161 DE-Gla1 DE-Zi4 DE-15 DE-Pl11 DE-Rs1 DE-105 DE-14 DE-Ch1 DE-L229 |
| imprint |
American Society for Microbiology, 1993 |
| imprint_str_mv |
American Society for Microbiology, 1993 |
| issn |
0066-4804 1098-6596 |
| issn_str_mv |
0066-4804 1098-6596 |
| language |
English |
| mega_collection |
American Society for Microbiology (CrossRef) |
| match_str |
morris1993useofrifampininnonstaphylococcalnonmycobacterialdisease |
| publishDateSort |
1993 |
| publisher |
American Society for Microbiology |
| recordtype |
ai |
| record_format |
ai |
| series |
Antimicrobial Agents and Chemotherapy |
| source_id |
49 |
| title |
Use of rifampin in nonstaphylococcal, nonmycobacterial disease |
| title_unstemmed |
Use of rifampin in nonstaphylococcal, nonmycobacterial disease |
| title_full |
Use of rifampin in nonstaphylococcal, nonmycobacterial disease |
| title_fullStr |
Use of rifampin in nonstaphylococcal, nonmycobacterial disease |
| title_full_unstemmed |
Use of rifampin in nonstaphylococcal, nonmycobacterial disease |
| title_short |
Use of rifampin in nonstaphylococcal, nonmycobacterial disease |
| title_sort |
use of rifampin in nonstaphylococcal, nonmycobacterial disease |
| topic |
Infectious Diseases Pharmacology (medical) Pharmacology |
| url |
http://dx.doi.org/10.1128/aac.37.1.1 |
| publishDate |
1993 |
| physical |
1-7 |
| description |
<jats:p>Rifampin has very broad antimicrobial properties with in vitro activities against many bacteria, mycobacteria, higher bacteria, chlamydia, fungi, parasites, and viruses (Table 1). The clinical use of rifampin is more limited, in part because of the lack of in vivo human clinical studies demonstrating its efficacy. Investigators have valid concerns regarding the emergence of resistance of mycobacteria if widespread use of rifampin becomes common, although this has not been well documented. Because rifampin obtains therapeutic levels intracellularly and is distributed widely throughout the body, the antibiotic potentially could be used on a broader scale, but more studies will be needed to demonstrate its clinical utility.</jats:p> |
| container_issue |
1 |
| container_start_page |
1 |
| container_title |
Antimicrobial Agents and Chemotherapy |
| container_volume |
37 |
| format_de105 |
Article, E-Article |
| format_de14 |
Article, E-Article |
| format_de15 |
Article, E-Article |
| format_de520 |
Article, E-Article |
| format_de540 |
Article, E-Article |
| format_dech1 |
Article, E-Article |
| format_ded117 |
Article, E-Article |
| format_degla1 |
E-Article |
| format_del152 |
Buch |
| format_del189 |
Article, E-Article |
| format_dezi4 |
Article |
| format_dezwi2 |
Article, E-Article |
| format_finc |
Article, E-Article |
| format_nrw |
Article, E-Article |
| _version_ |
1792336975627288577 |
| geogr_code |
not assigned |
| last_indexed |
2024-03-01T15:08:59.315Z |
| geogr_code_person |
not assigned |
| openURL |
url_ver=Z39.88-2004&ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fvufind.svn.sourceforge.net%3Agenerator&rft.title=Use+of+rifampin+in+nonstaphylococcal%2C+nonmycobacterial+disease&rft.date=1993-01-01&genre=article&issn=1098-6596&volume=37&issue=1&spage=1&epage=7&pages=1-7&jtitle=Antimicrobial+Agents+and+Chemotherapy&atitle=Use+of+rifampin+in+nonstaphylococcal%2C+nonmycobacterial+disease&aulast=Sands&aufirst=M&rft_id=info%3Adoi%2F10.1128%2Faac.37.1.1&rft.language%5B0%5D=eng |
| SOLR | |
| _version_ | 1792336975627288577 |
| author | Morris, A B, Brown, R B, Sands, M |
| author_facet | Morris, A B, Brown, R B, Sands, M, Morris, A B, Brown, R B, Sands, M |
| author_sort | morris, a b |
| container_issue | 1 |
| container_start_page | 1 |
| container_title | Antimicrobial Agents and Chemotherapy |
| container_volume | 37 |
| description | <jats:p>Rifampin has very broad antimicrobial properties with in vitro activities against many bacteria, mycobacteria, higher bacteria, chlamydia, fungi, parasites, and viruses (Table 1). The clinical use of rifampin is more limited, in part because of the lack of in vivo human clinical studies demonstrating its efficacy. Investigators have valid concerns regarding the emergence of resistance of mycobacteria if widespread use of rifampin becomes common, although this has not been well documented. Because rifampin obtains therapeutic levels intracellularly and is distributed widely throughout the body, the antibiotic potentially could be used on a broader scale, but more studies will be needed to demonstrate its clinical utility.</jats:p> |
| doi_str_mv | 10.1128/aac.37.1.1 |
| facet_avail | Online, Free |
| finc_class_facet | Medizin, Chemie und Pharmazie |
| format | ElectronicArticle |
| format_de105 | Article, E-Article |
| format_de14 | Article, E-Article |
| format_de15 | Article, E-Article |
| format_de520 | Article, E-Article |
| format_de540 | Article, E-Article |
| format_dech1 | Article, E-Article |
| format_ded117 | Article, E-Article |
| format_degla1 | E-Article |
| format_del152 | Buch |
| format_del189 | Article, E-Article |
| format_dezi4 | Article |
| format_dezwi2 | Article, E-Article |
| format_finc | Article, E-Article |
| format_nrw | Article, E-Article |
| geogr_code | not assigned |
| geogr_code_person | not assigned |
| id | ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTEyOC9hYWMuMzcuMS4x |
| imprint | American Society for Microbiology, 1993 |
| imprint_str_mv | American Society for Microbiology, 1993 |
| institution | DE-D275, DE-Bn3, DE-Brt1, DE-Zwi2, DE-D161, DE-Gla1, DE-Zi4, DE-15, DE-Pl11, DE-Rs1, DE-105, DE-14, DE-Ch1, DE-L229 |
| issn | 0066-4804, 1098-6596 |
| issn_str_mv | 0066-4804, 1098-6596 |
| language | English |
| last_indexed | 2024-03-01T15:08:59.315Z |
| match_str | morris1993useofrifampininnonstaphylococcalnonmycobacterialdisease |
| mega_collection | American Society for Microbiology (CrossRef) |
| physical | 1-7 |
| publishDate | 1993 |
| publishDateSort | 1993 |
| publisher | American Society for Microbiology |
| record_format | ai |
| recordtype | ai |
| series | Antimicrobial Agents and Chemotherapy |
| source_id | 49 |
| spelling | Morris, A B Brown, R B Sands, M 0066-4804 1098-6596 American Society for Microbiology Infectious Diseases Pharmacology (medical) Pharmacology http://dx.doi.org/10.1128/aac.37.1.1 <jats:p>Rifampin has very broad antimicrobial properties with in vitro activities against many bacteria, mycobacteria, higher bacteria, chlamydia, fungi, parasites, and viruses (Table 1). The clinical use of rifampin is more limited, in part because of the lack of in vivo human clinical studies demonstrating its efficacy. Investigators have valid concerns regarding the emergence of resistance of mycobacteria if widespread use of rifampin becomes common, although this has not been well documented. Because rifampin obtains therapeutic levels intracellularly and is distributed widely throughout the body, the antibiotic potentially could be used on a broader scale, but more studies will be needed to demonstrate its clinical utility.</jats:p> Use of rifampin in nonstaphylococcal, nonmycobacterial disease Antimicrobial Agents and Chemotherapy |
| spellingShingle | Morris, A B, Brown, R B, Sands, M, Antimicrobial Agents and Chemotherapy, Use of rifampin in nonstaphylococcal, nonmycobacterial disease, Infectious Diseases, Pharmacology (medical), Pharmacology |
| title | Use of rifampin in nonstaphylococcal, nonmycobacterial disease |
| title_full | Use of rifampin in nonstaphylococcal, nonmycobacterial disease |
| title_fullStr | Use of rifampin in nonstaphylococcal, nonmycobacterial disease |
| title_full_unstemmed | Use of rifampin in nonstaphylococcal, nonmycobacterial disease |
| title_short | Use of rifampin in nonstaphylococcal, nonmycobacterial disease |
| title_sort | use of rifampin in nonstaphylococcal, nonmycobacterial disease |
| title_unstemmed | Use of rifampin in nonstaphylococcal, nonmycobacterial disease |
| topic | Infectious Diseases, Pharmacology (medical), Pharmacology |
| url | http://dx.doi.org/10.1128/aac.37.1.1 |